| 2025 * | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Balance Sheet ($000) | |||||
| Cash & Short-Term Investments | 84,273 | 64,166 | 47,700 | 51,889 | 66,966 |
| Total Assets | 1,035,105 | 808,404 | 617,757 | 542,087 | 564,723 |
| Total Debt | 236,123 | 157,624 | 130,921 | 116,395 | 107,051 |
| Total Liabilities | 450,831 | 358,541 | 275,923 | 238,270 | 245,261 |
| Net Assets Without Donor Restrictions | 467,371 | 329,972 | 248,073 | 207,230 | 219,856 |
| Total Net Assets | 510,738 | 369,501 | 295,160 | 257,813 | 266,111 |
| Statement of Operations ($000) | |||||
| Net Patient Rev | 720,532 | 566,125 | 441,545 | 386,606 | 353,403 |
| Total Operating Exp | 829,818 | 620,215 | 499,452 | 440,473 | 395,506 |
| Adjusted Net Operating Income | 6,109 | 2,207 | -358 | 719 | 7,964 |
| Revenue Over Expenses | 23,214 | 12,211 | 3,037 | 2,132 | 17,389 |
| Liquidity | |||||
| Days Cash on Hand | 179.1 | 173.0 | 171.3 | 181.1 | 231.5 |
| Current Ratio | 2.02 | 1.95 | 1.94 | 1.89 | 1.81 |
| Payment Period | 65.0 | 65.7 | 64.0 | 68.2 | 88.1 |
| Capital | |||||
| Average Age Net Fixed Assets (yrs) | 12.8 | 12.8 | 12.7 | 12.6 | 12.6 |
| Long-Term Debt / Capitalization % | 26.2 | 28.0 | 29.2 | 29.6 | 28.1 |
| Total Debt / Capitalization % | 28.91 | 30.60 | 31.84 | 32.15 | 30.31 |
| Leverage | |||||
| Current Debt Service Cov | 3.99 | 3.35 | 2.63 | 2.75 | 5.05 |
| Cashflow / Total Debt % | 28.54 | 23.51 | 17.47 | 18.51 | 35.36 |
| Financial Condition | |||||
| EBIDA Margin % | 9.31 | 8.57 | 6.92 | 6.80 | 12.04 |
| Adjusted Operating Margin % | 1.53 | 0.85 | -0.19 | 0.34 | 3.44 |
| Profit Margin % | 4.26 | 2.96 | 1.28 | 1.33 | 6.17 |
| Profile | |||||
| Beds In Service | 380 | 357 | 304 | 301 | 298 |
| Admissions | 17,616 | 15,865 | 14,059 | 12,903 | 12,635 |
| Patient Days | 101,946 | 96,896 | 80,285 | 80,664 | 71,870 |
| ER Visits | 95,419 | 88,295 | 74,965 | 71,439 | 61,775 |
| Balance Sheet ($000) | |
|---|---|
| Cash & Short-Term Investments | |
| 2025 * | 84,273 |
| 2024 | 64,166 |
| 2023 | 47,700 |
| 2022 | 51,889 |
| 2021 | 66,966 |
| Total Assets | |
| 2025 * | 1,035,105 |
| 2024 | 808,404 |
| 2023 | 617,757 |
| 2022 | 542,087 |
| 2021 | 564,723 |
| Total Debt | |
| 2025 * | 236,123 |
| 2024 | 157,624 |
| 2023 | 130,921 |
| 2022 | 116,395 |
| 2021 | 107,051 |
| Total Liabilities | |
| 2025 * | 450,831 |
| 2024 | 358,541 |
| 2023 | 275,923 |
| 2022 | 238,270 |
| 2021 | 245,261 |
| Net Assets Without Donor Restrictions | |
| 2025 * | 467,371 |
| 2024 | 329,972 |
| 2023 | 248,073 |
| 2022 | 207,230 |
| 2021 | 219,856 |
| Total Net Assets | |
| 2025 * | 510,738 |
| 2024 | 369,501 |
| 2023 | 295,160 |
| 2022 | 257,813 |
| 2021 | 266,111 |
| Statement of Operations ($000) | |
| Net Patient Rev | |
| 2025 * | 720,532 |
| 2024 | 566,125 |
| 2023 | 441,545 |
| 2022 | 386,606 |
| 2021 | 353,403 |
| Total Operating Exp | |
| 2025 * | 829,818 |
| 2024 | 620,215 |
| 2023 | 499,452 |
| 2022 | 440,473 |
| 2021 | 395,506 |
| Adjusted Net Operating Income | |
| 2025 * | 6,109 |
| 2024 | 2,207 |
| 2023 | -358 |
| 2022 | 719 |
| 2021 | 7,964 |
| Revenue Over Expenses | |
| 2025 * | 23,214 |
| 2024 | 12,211 |
| 2023 | 3,037 |
| 2022 | 2,132 |
| 2021 | 17,389 |
| Liquidity | |
| Days Cash on Hand | |
| 2025 * | 179.1 |
| 2024 | 173.0 |
| 2023 | 171.3 |
| 2022 | 181.1 |
| 2021 | 231.5 |
| Current Ratio | |
| 2025 * | 2.02 |
| 2024 | 1.95 |
| 2023 | 1.94 |
| 2022 | 1.89 |
| 2021 | 1.81 |
| Payment Period | |
| 2025 * | 65.0 |
| 2024 | 65.7 |
| 2023 | 64.0 |
| 2022 | 68.2 |
| 2021 | 88.1 |
| Capital | |
| Average Age Net Fixed Assets (yrs) | |
| 2025 * | 12.8 |
| 2024 | 12.8 |
| 2023 | 12.7 |
| 2022 | 12.6 |
| 2021 | 12.6 |
| Long-Term Debt / Capitalization % | |
| 2025 * | 26.2 |
| 2024 | 28.0 |
| 2023 | 29.2 |
| 2022 | 29.6 |
| 2021 | 28.1 |
| Total Debt / Capitalization % | |
| 2025 * | 28.91 |
| 2024 | 30.60 |
| 2023 | 31.84 |
| 2022 | 32.15 |
| 2021 | 30.31 |
| Leverage | |
| Current Debt Service Cov | |
| 2025 * | 3.99 |
| 2024 | 3.35 |
| 2023 | 2.63 |
| 2022 | 2.75 |
| 2021 | 5.05 |
| Cashflow / Total Debt % | |
| 2025 * | 28.54 |
| 2024 | 23.51 |
| 2023 | 17.47 |
| 2022 | 18.51 |
| 2021 | 35.36 |
| Financial Condition | |
| EBIDA Margin % | |
| 2025 * | 9.31 |
| 2024 | 8.57 |
| 2023 | 6.92 |
| 2022 | 6.80 |
| 2021 | 12.04 |
| Adjusted Operating Margin % | |
| 2025 * | 1.53 |
| 2024 | 0.85 |
| 2023 | -0.19 |
| 2022 | 0.34 |
| 2021 | 3.44 |
| Profit Margin % | |
| 2025 * | 4.26 |
| 2024 | 2.96 |
| 2023 | 1.28 |
| 2022 | 1.33 |
| 2021 | 6.17 |
| Profile | |
| Beds In Service | |
| 2025 * | 380 |
| 2024 | 357 |
| 2023 | 304 |
| 2022 | 301 |
| 2021 | 298 |
| Admissions | |
| 2025 * | 17,616 |
| 2024 | 15,865 |
| 2023 | 14,059 |
| 2022 | 12,903 |
| 2021 | 12,635 |
| Patient Days | |
| 2025 * | 101,946 |
| 2024 | 96,896 |
| 2023 | 80,285 |
| 2022 | 80,664 |
| 2021 | 71,870 |
| ER Visits | |
| 2025 * | 95,419 |
| 2024 | 88,295 |
| 2023 | 74,965 |
| 2022 | 71,439 |
| 2021 | 61,775 |
* Median values are based upon the number of audits received at any given point in time. Therefore, the median values for the most recent year(s) are subject to frequent updating and may not yet accurately characterize the median values of a complete sample size.
